GroupAccess > Drug Coverage Guidelines

You are not signed in.

myBlueCross for Members
Forgot Username?
Forgot Password?

New to GroupAccess?

 

Search by Drug Name

  

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Product Name Implementation Date Guideline
GAMMAGARD LIQUID 10/01/14 Prior authorization for medical necessity is required.
GAMMAKED 10/01/14 Prior authorization for medical necessity is required.
GAMUNEX-C® 01/01/12 Prior authorization for medical necessity is required.
GATTEX® 07/01/13 Prior authorization for medical necessity is required.
GENOTROPIN® 10/01/11 Prior authorization for medical necessity is required. Use of the preferred growth hormone, Omnitrope, may be required.
GILENYA® 01/01/11 Gilenya may be subject to step therapy. Patients must have trial and failure of one of the five preferred products: Betaseron, Copaxone, Plegridy, Rebif or Tecfidera. The limits are 1 tablet per day.
GILOTRIF® 01/01/14 Prior authorization for medical necessity is required. The limits are 1 tablets per day.
GLEEVEC® 05/01/01 Prior authorization for medical necessity is required. The limits are 3 tablets per day for 100mg or 2 tablets per day for 400mg.
GLYXAMBI® 07/01/15 Prior authorization for medical necessity is required. The limits are 1 tablet per day.
GRALISE® 01/01/12 The limits are 30 capsules per 30 days for 300mg tablets, 90 tablets per 30 days for 600mg tablets, and 1 starter pack per 30 days.
GRANISOL 04/01/12 The limits are 60 mL (2 bottles) per 30 days.